Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 15, 2020
Tumefactive multiple sclerosis in association with fingolimod initiation and discontinuationDavid Croteau, Anne Tobenkin, Allen Brinker, et al.
Headache|January 10, 2021
Hypertension: A new safety risk for patients treated with erenumabSuprat Saely, David Croteau, Laura Jawidzik, et al.
Pharmacoepidemiology and Drug Safety|April 24, 2020
Association of eszopiclone, zaleplon, or zolpidem with complex sleep behaviors resulting in serious injuries, including deathKelly Harbourt, Ofir N Nevo, Rongmei Zhang, et al.
Neurology|April 1, 2018
Acute acalculous cholecystitis: A new safety risk for patients with MS treated with alemtuzumabDavid Croteau, Charlene Flowers, Corrinne G Kulick, et al.
Technology in Cancer Research & Treatment|May 17, 2006
Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapyMitomu Kioi, Syed R Husain, David Croteau, et al.
Journal of Neurology|April 18, 2026
Corneal edema: an underrecognized safety risk of amantadineDavid Croteau, Anne Tobenkin, Vicky Chan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 10, 2020
Expanding spectrum of opportunistic infections associated with dimethyl fumarateTiffany Kim, David Croteau, Allen Brinker, et al.
Journal of Neuro-Oncology|May 1, 2010
Phase I/II dose escalation trial of concurrent temozolomide and whole brain radiation therapy for multiple brain metastasisTom Mikkelsen, Joe Anderson, Thomas J Doyle, et al.
Pageof 4